StockIQpro
NASDAQ:PROK

Prokidney Corp.

Prokidney Corp.'s revenue grew 1075.0% in fiscal 2025 to $893,000 while operating margin rose to −18477.8%. Free cash flow was −$135.3M, −15152.6% of revenue.Summary generated from Prokidney Corp.'s SEC filings. Latest annual report filed Mar 18, 2026.

Revenue (FY25)$893,000
Revenue growth+1075.0%
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating margin−18477.8%
Net margin−7725.2%
ROICn/a
Return on equityn/a
Debt / equityn/a
Free cash flow−$135.3M
FCF margin−15152.6%
Share count changen/a

Financials

Fiscal years, $M
Item20212022202320242025
Revenuen/a0001
Operating income−55−153−152−184−165
Net income−55−148−35−61−69
Free cash flow−55−79−124−156−135

Recent filings

From SEC EDGAR

Peers

Biological products, (no diagnostic substances)